16.08.2023 - Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced financial results for the three and six months ended June 30, 2023 and provided a business .
Athersys (ATHX) Reports Q2, Provides Updates streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced financial results for the three and six months ended June 30, 2023 and. -Today at 05:02 pm- MarketScreener
Athersys Reports Second Quarter 2023 Financial Results and Business Highlights streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Rockwell Medical Announces Second Quarter 2023 Results itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.